Neogen (NEOG) Construction in Progress (2011 - 2025)
Neogen's (NEOG) quarterly Construction in Progress came in at $186.2 million in Q2 2025, up 63.42% year-on-year from $114.0 million in Q2 2024, and up 63.42% quarter-over-quarter from $114.0 million in Q2 2024.
Neogen (NEOG) Construction in Progress (2011 - 2025) Analysis & Trends
Neogen's Construction in Progress history runs 15 years deep, the most recent figure standing at $186.2 million for Q2 2025.
- On a quarterly basis, Construction in Progress rose 63.42% year-over-year to $186.2 million in Q2 2025; TTM through May 2025 was $186.2 million, a 63.42% increase from a year earlier, with the FY2025 full-year figure at $186.2 million, up 63.42% from the prior year.
- Construction in Progress improved to $186.2 million in Q2 2025 per NEOG's latest filing, from $114.0 million in the prior quarter.
- Across five years, Construction in Progress topped out at $186.2 million in Q2 2025 and bottomed at $3.3 million in Q2 2021.
- The 5-year median for Construction in Progress is $52.2 million (2023), against an average of $72.3 million.
- Across the five-year window, Construction in Progress plunged 34.36% in 2021 and surged 774.41% in 2023, its largest moves.
- Year by year, Construction in Progress stood at $3.3 million in 2021, then jumped by 83.2% to $6.0 million in 2022, then surged by 774.41% to $52.2 million in 2023, then jumped by 118.17% to $114.0 million in 2024, then surged by 63.42% to $186.2 million in 2025.
- Per Business Quant, the three latest NEOG Construction in Progress figures stand at $186.2 million (Q2 2025), $114.0 million (Q2 2024), and $52.2 million (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | - |
| 10 | Neogen | 2.06 Bn | 1.90 Bn | 99.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | 186.24 Mn |
| May 31, 2024 | 113.97 Mn |
| May 31, 2023 | 52.24 Mn |
| May 31, 2022 | 5.97 Mn |
| May 31, 2021 | 3.26 Mn |
| May 31, 2020 | 4.97 Mn |
| May 31, 2019 | 2.29 Mn |
| May 31, 2018 | 2.65 Mn |
| May 31, 2017 | 2.29 Mn |
| May 31, 2016 | 1.06 Mn |
| May 31, 2015 | 783,000.00 |
| May 31, 2014 | 1.66 Mn |
| May 31, 2013 | 1.56 Mn |
| May 31, 2012 | 590,000.00 |
| May 31, 2011 | 1.22 Mn |